Apogee Therapeutics (APGE) Shares Issued (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly Shares Issued of $2.2 million for Q1 2026, up 124.96% year-over-year from $962645.0 in Q1 2025, and down 61.4% quarter-over-quarter from $5.6 million in Q4 2025.
Apogee Therapeutics (APGE) Shares Issued (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Shares Issued for 5 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 124.96% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 124.96% YoY), while the FY2025 annual figure was $5.6 million, up 8.83% from the prior year.
- Shares Issued declined to $2.2 million in Q1 2026 per APGE's latest filing, from $5.6 million in the prior quarter.
- Across five years, Shares Issued topped out at $5.7 million in Q2 2025 and bottomed at $99955.0 in Q1 2024.
- Historically, Shares Issued has averaged $2.8 million across 5 years, with a median of $2.5 million in 2023.
- Annual changes were most pronounced in 2024 — Shares Issued retreated 21.97% — and 2025, when it jumped 1043.54%.
- Apogee Therapeutics' Shares Issued stood at $2.8 million in 2022, then retreated by 9.34% to $2.5 million in 2023, then surged by 105.72% to $5.2 million in 2024, then advanced by 8.83% to $5.6 million in 2025, then plunged by 61.4% to $2.2 million in 2026.
- Business Quant data shows APGE's Shares Issued at $2.2 million in Q1 2026, $5.6 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 6.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.63 Mn |
| Jun 30, 2026 | 6.63 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | 5.69 Mn |
| Sep 30, 2025 | 5.69 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 962,645.00 |
| Mar 31, 2025 | 962,645.00 |
| Dec 31, 2024 | 5.16 Mn |
| Dec 31, 2024 | 5.16 Mn |
| Sep 30, 2024 | 497,473.00 |
| Sep 30, 2024 | 497,473.00 |
| Jun 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 99,955.00 |
| Mar 31, 2024 | 99,955.00 |